PharmiWeb.com - Global Pharma News & Resources

PressReleases - 2019-06-02

Date Title Company
02-Jun-2019 Vascepa® to Be Featured in Multiple Scientific Sessions at the National Lipid Association Annual Meeting Vascepa
02-Jun-2019 Sofinnova Partners’ DNA Script Raises $38.5 Million in Series B Financing Sofinnova
02-Jun-2019 Nobel Prize-winning stem cell researcher, Professor Shinya Yamanaka, visits CGT Catapult CGT Catapult
02-Jun-2019 SkinBioTherapeutics shortlisted for Best Technology at European Mediscience Awards 2019 SkinBioTherapeutics
02-Jun-2019 Presentations highlight Lynparza’s benefit in PARP-mediated cancers and Imfinzi’s three-year overall survival in unresectable, Stage III non-small cell lung cancer AstraZeneca
02-Jun-2019 Acquisition enhances ICON’s patient access in Europe and Africa ICON
02-Jun-2019 Genmab Files Registration Statement in the United States for a Proposed Public Offering of American Depositary Shares (ADSs) and Applies for Listing of the ADSs on Nasdaq Genmab
02-Jun-2019 Sermonix Receives FDA Fast Track Designation for Investigational Drug Lasofoxifene Sermonix
02-Jun-2019 First Czech Republic Diabetic Patient with Critical Limb Ischaemia Treated with Novel Regenerative Therapy by Associate Professor Václav Procházka at University Hospital Ostrava Rexgenero
02-Jun-2019 Orion Biotechnology's Chief Medical Officer to Present at the American Society of Clinical Oncology (ASCO) Meeting in Chicago Orion Biotechnology
02-Jun-2019 2019 American Society of Clinical Oncology (ASCO) Annual Meeting - Darolutamide data presented Bayer
02-Jun-2019 Cantargia: Presentation of Phase I Clinical Data on Antibody CAN04 at ASCO Cantargia AB
02-Jun-2019 BerGenBio Presents New Preliminary Clinical and Biomarker Data Showing Durable Response & Median Survival Rates in Phase II Trial With Bemcentinib and KEYTRUDA in Pts With Advanced NSCLC at ASCO 2019 BerGenBio ASA
02-Jun-2019 SOTIO’s DCVAC/LuCa Significantly Improves Survival in Patients with Stage IV Non-small Cell Lung Cancer B3C newswire
02-Jun-2019 Daiichi Sankyo Presents Preliminary Phase 1 Data for TROP2 Targeting ADC DS-1062 in Patients with Non-Small Cell Lung Cancer at 2019 ASCO Annual Meeting Daiichi Sankyo Company, Limited
02-Jun-2019 Threonine Acids Market Insight Study of Future Value Chain on Size, Share, Volume and Revenue in-Depth 2019-2028 Wired Release
02-Jun-2019 Sport Medicine Market 2019 : Outlooks, Research, Trends and Forecast to 2028 Wired Release
02-Jun-2019 Spinal Intervention Market Key Players,Analysis and Forecast 2019 to 2028 Wired Release
02-Jun-2019 Global Specialty Enzymes Market To Grow with Healthy CAGR 2028 Wired Release
02-Jun-2019 Small Animal Imaging (In-vivo) Market | Global Research Insights 2019-2028 Wired Release